The results indicated that TMEM43 ARVD mutant accelerates fibrosis progresses in both dermal fibroblasts (Fig. S4) and cardiac fibroblasts (Fig. S5). This evidence concerns the gene TMEM43 and arrhythmogenic right ventricular cardiomyopathy.